Phase 3 studies point to sustained disease control in patients who remain symptomatic despite standard therapies.
Executives on a DealBook Summit task force panel said fear was not the way to build teams capable of navigating difficult ...
Chronic chikungunya arthritis often mimics rheumatoid arthritis, complicating diagnosis and therapy, and necessitating ...
The European Medicines Agency has recommended the approval of GSK's add-on drug to treat asthma and a chronic inflammatory ...
Dec 11 (Reuters) - The U.S. Food and Drug Administration said on Thursday it has expanded the use of GSK's Blujepa as an oral ...
The boss of Britain’s largest drug developer has praised the US as the best place to invest amid fears over the waning appeal ...
On Friday, the F.D.A. approved a new antibiotic, zoliflodacin, a day after an article published in The Lancet reported that a ...
AKEEGA ® U.S. Prescribing Information. 2 Olmos D, Lorente D, Jambrina A, et al. BRCA1/2 and homologous recombination repair alterations in high- and low-volume ...
DelveInsight’s “Post Traumatic Stress Disorder Market Insights, Epidemiology, and Market Forecast-2034″ report offers an ...
TipRanks on MSN
GSK enhances shareholder value with continued share buyback
The latest announcement is out from GlaxoSmithKline ( ($GB:GSK) ). GlaxoSmithKline (GSK) announced the purchase of 250,000 of its own ordinary ...
TipRanks on MSN
GSK Pharmaceuticals faces GST demand order
GlaxoSmithKline Pharmaceuticals Limited ( ($IN:GLAXO) ) has shared an update. GlaxoSmithKline Pharmaceuticals Limited has received an order from ...
FIDSON Healthcare Plc has reinforced its commitment to healthcare delivery, corporate governance, and strategic growth ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback